Page last updated: 2024-10-30

meclofenamic acid and Glomerulosclerosis, Focal Segmental

meclofenamic acid has been researched along with Glomerulosclerosis, Focal Segmental in 1 studies

Meclofenamic Acid: A non-steroidal anti-inflammatory agent with antipyretic and antigranulation activities. It also inhibits prostaglandin biosynthesis.
meclofenamic acid : An aminobenzoic acid that is anthranilic acid in which one of the hydrogens attached to the nitrogen is replaced by a 2,6-dichloro-3-methylphenyl group. A non-steroidal anti-inflammatory drug, it is used as the sodium salt for the treatment of dysmenorrhoea (painful periods), osteoarthritis and rheumatoid arthritis.

Glomerulosclerosis, Focal Segmental: A clinicopathological syndrome or diagnostic term for a type of glomerular injury that has multiple causes, primary or secondary. Clinical features include PROTEINURIA, reduced GLOMERULAR FILTRATION RATE, and EDEMA. Kidney biopsy initially indicates focal segmental glomerular consolidation (hyalinosis) or scarring which can progress to globally sclerotic glomeruli leading to eventual KIDNEY FAILURE.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Torres, VE1
Velosa, JA1
Holley, KE1
Frohnert, PP1
Zincke, H1
Sterioff, S1

Other Studies

1 other study available for meclofenamic acid and Glomerulosclerosis, Focal Segmental

ArticleYear
Meclofenamate treatment of recurrent idiopathic nephrotic syndrome with focal segmental glomerulosclerosis after renal transplantation.
    Mayo Clinic proceedings, 1984, Volume: 59, Issue:3

    Topics: Adult; Creatinine; Glomerulonephritis; Glomerulosclerosis, Focal Segmental; Humans; Kidney Transplan

1984